MarketPeel
Insider Trading Intelligence
Pricing
…
BL

Bp Directors, Lp

LTRN
10% OWNER · LANTERN PHARMA INC. · CIK 0001813311
FILING MIX · LIFETIME35%/65%
BUYS
56
SELLS
103
TOTAL VALUE
$9.62M
COMPANIES
4
ACTIVE SINCE
Jun 2020
HOLDINGS NOW
618,106
AVG SELL PX
$4.36
TRADE KIND
SHOWING 159 / 159
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
54 backtested trades · 8 horizons · 35 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Bp Directors, Lp, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d54+29.63%+5.97%+0.38%+5.59%+5.78%4.02
14d54+29.63%+11.52%+1.83%+9.69%+1.23%3.31
30d54+9.26%+21.77%+3.54%+18.24%+5.20%4.54
60d54+9.26%+32.33%+5.82%+26.52%+25.54%5.00
90d54+3.70%+27.81%+8.13%+19.68%+18.70%6.42
180d54+11.11%+12.47%+13.59%-1.12%+2.42%-0.48
1y54+29.63%+0.12%+23.05%-25.83%-10.94%-5.70
2y54(35 pending)+84.21%-38.93%+43.76%-82.69%-75.02%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
LTRN · 373,178 shares · as of Jun 13, 2025
0167,185334,369501,554668,73820212022202320242025SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
FLOW · 56 buys / 103 sellsCOVERAGE · 21 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
71,428——71,428Jun 27, 2025Jun 30, 2025 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
71,428$7.00$500.0K196,428Jun 27, 2025Jun 30, 2025 ↗View →
CGTX
COGNITION THERAPEUTICS INC
PURCHASEGRANT
Stock grant
34,000——48,500Jun 18, 2025Jun 20, 2025 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
1,903$3.09$5.9K49,957Jun 13, 2025Jun 13, 2025 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
12,319$3.09$38.1K323,335Jun 13, 2025Jun 13, 2025 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
7,206$3.09$22.3K189,117Jun 13, 2025Jun 13, 2025 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
4,354$3.09$13.5K114,272Jun 13, 2025Jun 13, 2025 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
14,218$3.09$43.9K373,178Jun 13, 2025Jun 13, 2025 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
2,886$3.38$9.8K51,860Jun 12, 2025Jun 12, 2025 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
6,601$3.38$22.3K118,626Jun 12, 2025Jun 12, 2025 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
18,678$3.38$63.1K335,654Jun 12, 2025Jun 12, 2025 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
21,557$3.38$72.9K387,396Jun 12, 2025Jun 12, 2025 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
10,925$3.38$36.9K196,323Jun 12, 2025Jun 12, 2025 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
171$3.40$581207,248Jun 11, 2025Jun 12, 2025 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
45$3.40$15354,746Jun 11, 2025Jun 12, 2025 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
293$3.40$996354,332Jun 11, 2025Jun 12, 2025 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
103$3.40$350125,227Jun 11, 2025Jun 12, 2025 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
338$3.40$1.1K408,953Jun 11, 2025Jun 12, 2025 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
5$3.40$17409,291Jun 10, 2025Jun 12, 2025 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
1$3.40$354,791Jun 10, 2025Jun 12, 2025 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
5$3.40$17354,625Jun 10, 2025Jun 12, 2025 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
3$3.40$10207,419Jun 10, 2025Jun 12, 2025 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
2$3.40$7125,330Jun 10, 2025Jun 12, 2025 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
961$3.03$2.9K54,792May 29, 2025May 29, 2025 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
6,221$3.03$18.8K354,630May 29, 2025May 29, 2025 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
2,199$3.03$6.7K125,332May 29, 2025May 29, 2025 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
7,180$3.03$21.8K409,296May 29, 2025May 29, 2025 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
3,639$3.03$11.0K207,422May 29, 2025May 29, 2025 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
714$2.87$2.0K55,753May 28, 2025May 29, 2025 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
1,632$2.87$4.7K127,531May 28, 2025May 29, 2025 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
2,702$2.87$7.8K211,061May 28, 2025May 29, 2025 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
5,332$2.87$15.3K416,476May 28, 2025May 29, 2025 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
4,620$2.87$13.3K360,851May 28, 2025May 29, 2025 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
7,478$3.05$22.8K421,808May 27, 2025May 29, 2025 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
3,790$3.05$11.6K213,763May 27, 2025May 29, 2025 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
6,479$3.05$19.8K365,471May 27, 2025May 29, 2025 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
2,290$3.05$7.0K129,163May 27, 2025May 29, 2025 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
1,000$3.05$3.0K56,467May 27, 2025May 29, 2025 ↗View →
INAB
IN8BIO, INC.
SALE
574,241——0May 2, 2025May 7, 2025 ↗View →
INAB
IN8BIO, INC.
PURCHASE
1,148,482——2,431,763May 2, 2025May 7, 2025 ↗View →
INAB
IN8BIO, INC.
SALE
574,241——0May 2, 2025May 7, 2025 ↗View →
INAB
IN8BIO, INC.
PURCHASE
709,040——1,283,281Oct 4, 2024Oct 11, 2024 ↗View →
INAB
IN8BIO, INC.
PURCHASE
574,241——0Oct 4, 2024Oct 11, 2024 ↗View →
INAB
IN8BIO, INC.
PURCHASEGRANT
Stock grant
574,241——574,241Oct 4, 2024Oct 11, 2024 ↗View →
INAB
IN8BIO, INC.
PURCHASE
709,040——709,040Oct 4, 2024Oct 11, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
307,538——307,538Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
176,499——638,572Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
SALE
147,047——0Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
573,394——573,394Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
78,267——404,814Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
SALE
525,797——0Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
SALE
141,457——0Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
SALE
17,361$9.00$156.2K980,433Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
884,427——884,427Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
61,857——61,857Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
125,000$8.00$1.00M125,000Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
SALE
74,202——0Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
SALE
2,022,029——0Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
44,559——130,044Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
SALE
78,267——0Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
SALE
8,068——0Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
SALE
326,547——0Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
309,589——309,589Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
SALE
54,032——0Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
SALE
153,702——0Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
101,900——297,389Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
SALE
309,589——0Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
484,638——2,506,667Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
SALE
5,314$9.00$47.8K300,143Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
3,528$5.27$18.6K133,572Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
525,797——525,797Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
SALE
2,324$9.00$20.9K131,248Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
147,047——300,749Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
SALE
884,427——0Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
8,068$5.27$42.5K305,457Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
SALE
23,628——0Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
SALE
484,638——0Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
SALE
332,867——0Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
332,867——971,439Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
SALE
61,857——0Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
SALE
462,073——0Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
74,202——383,791Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
2,094,650——2,094,650Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
SALE
573,394——0Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
23,628——85,485Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
326,547——326,547Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
SALE
3,528——0Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
54,032——195,489Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
SALE
101,900——0Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
2,022,029——2,022,029Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
462,073——462,073Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
SALE
26,355——0Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
153,702——153,702Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
SALE
2,094,650——0Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
26,355$5.27$138.9K997,794Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
141,457——141,457Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
SALE
44,559——0Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
SALE
176,499——0Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
375,000$8.00$3.00M1,259,427Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
SALE
5,314$8.00$42.5K300,143Aug 14, 2024Aug 20, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
SALE
17,361$8.00$138.9K980,433Aug 14, 2024Aug 20, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
SALE
2,324$8.00$18.6K131,248Aug 14, 2024Aug 20, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
SALE
307,538——0Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
15,000——15,000Aug 12, 2024Aug 14, 2024 ↗View →
CGTX
COGNITION THERAPEUTICS INC
PURCHASEGRANT
Stock grant
8,500——14,500Jun 7, 2024Jun 11, 2024 ↗View →
CGTX
COGNITION THERAPEUTICS INC
PURCHASEGRANT
Stock grant
8,500——8,500Jun 7, 2024Jun 11, 2024 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
4,253$6.33$26.9K131,453May 24, 2024May 28, 2024 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
1,859$6.33$11.8K57,467May 24, 2024May 28, 2024 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
13,888$6.33$87.9K429,286May 24, 2024May 28, 2024 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
6,944$6.25$43.4K443,174May 23, 2024May 28, 2024 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
930$6.25$5.8K59,326May 23, 2024May 28, 2024 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
2,126$6.25$13.3K135,706May 23, 2024May 28, 2024 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
1,832$4.87$8.9K60,256Feb 29, 2024Feb 29, 2024 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
4,185$4.87$20.4K137,832Feb 29, 2024Feb 29, 2024 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
13,686$4.87$66.7K450,118Feb 29, 2024Feb 29, 2024 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
51,608$4.85$250.3K463,804Feb 28, 2024Feb 29, 2024 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
6,909$4.85$33.5K62,088Feb 28, 2024Feb 29, 2024 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
15,780$4.85$76.5K142,017Feb 28, 2024Feb 29, 2024 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
10,620$4.40$46.7K157,797Feb 27, 2024Feb 29, 2024 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
34,731$4.40$152.8K515,412Feb 27, 2024Feb 29, 2024 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
4,649$4.40$20.5K68,997Feb 27, 2024Feb 29, 2024 ↗View →
LTRN
LANTERN PHARMA INC.
PURCHASE
54,873$3.13$171.8K591,036Jan 17, 2024Jan 19, 2023 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
7,347——0Jan 17, 2024Jan 19, 2023 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
5,475$4.20$23.0K73,646Jan 17, 2024Jan 19, 2023 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
12,521$4.20$52.6K168,417Jan 17, 2024Jan 19, 2023 ↗View →
LTRN
LANTERN PHARMA INC.
PURCHASE
16,801$3.13$52.6K180,938Jan 17, 2024Jan 19, 2023 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
40,893$4.20$171.8K550,143Jan 17, 2024Jan 19, 2023 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
16,801——0Jan 17, 2024Jan 19, 2023 ↗View →
LTRN
LANTERN PHARMA INC.
PURCHASE
7,347$3.13$23.0K79,121Jan 17, 2024Jan 19, 2023 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
54,873——0Jan 17, 2024Jan 19, 2023 ↗View →
INAB
IN8BIO, INC.
PURCHASE
574,241——574,241Dec 13, 2023Dec 14, 2023 ↗View →
INAB
IN8BIO, INC.
PURCHASE
574,241——574,241Dec 13, 2023Dec 14, 2023 ↗View →
INAB
IN8BIO, INC.
PURCHASE
574,241——574,241Dec 13, 2023Dec 14, 2023 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
53,640$3.44$184.5K217,553Nov 29, 2023Dec 1, 2023 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
91,708$3.44$315.5K371,950Nov 29, 2023Dec 1, 2023 ↗View →
CGTX
COGNITION THERAPEUTICS INC
PURCHASEGRANT
Stock grant
500,095$1.05$525.1K500,095Nov 8, 2023Nov 13, 2023 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
132,575$4.40$583.3K536,163Nov 8, 2022Nov 9, 2022 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
58,711$4.40$258.3K271,193Nov 8, 2022Nov 9, 2022 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
40,586$4.40$178.6K164,137Nov 8, 2022Nov 9, 2022 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
17,748$4.40$78.1K71,774Nov 8, 2022Nov 9, 2022 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
100,380$4.40$441.7K463,658Nov 8, 2022Nov 9, 2022 ↗View →
LTRN
LANTERN PHARMA INC.
PURCHASE
6,438——0Sep 2, 2022Sep 7, 2022 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
5,170$5.20$26.9K20,930Sep 2, 2022Sep 7, 2022 ↗View →
LTRN
LANTERN PHARMA INC.
PURCHASE
6,438$1.03$6.6K27,328Sep 2, 2022Sep 7, 2022 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
1,275$5.20$6.6K26,093Sep 2, 2022Sep 7, 2022 ↗View →
LTRN
LANTERN PHARMA INC.
PURCHASE
26,100$1.03$26.9K26,100Sep 2, 2022Sep 7, 2022 ↗View →
LTRN
LANTERN PHARMA INC.
PURCHASE
26,100——6,438Sep 2, 2022Sep 7, 2022 ↗View →
LTRN
LANTERN PHARMA INC.
PURCHASEGRANT
Stock grant
3,200——3,200Nov 4, 2021Nov 8, 2021 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
289,429——0Jun 15, 2020Jun 16, 2020 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
35,181——0Jun 15, 2020Jun 16, 2020 ↗View →
LTRN
LANTERN PHARMA INC.
PURCHASE
61,214——89,522Jun 15, 2020Jun 16, 2020 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
262,806——0Jun 15, 2020Jun 16, 2020 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
80,454——0Jun 15, 2020Jun 16, 2020 ↗View →
LTRN
LANTERN PHARMA INC.
PURCHASE
457,282——668,738Jun 15, 2020Jun 16, 2020 ↗View →
LTRN
LANTERN PHARMA INC.
PURCHASE
503,606——503,606Jun 15, 2020Jun 16, 2020 ↗View →
LTRN
LANTERN PHARMA INC.
PURCHASE
294,557——294,557Jun 15, 2020Jun 16, 2020 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
169,286——0Jun 15, 2020Jun 16, 2020 ↗View →
LTRN
LANTERN PHARMA INC.
PURCHASE
139,989——204,723Jun 15, 2020Jun 16, 2020 ↗View →
LTRN
LANTERN PHARMA INC.
PURCHASEGRANT
Stock grant
9,135——9,135Jun 15, 2020Jun 16, 2020 ↗View →
Other insiders · LTRN
Loading peer insiders…
About this filer
CIK 0001813311
ROLE
10% Owner
PRIMARY
LTRN
COMPANIES
4
ACTIVE SINCE
Jun 2020
MARKETPEEL · /INSIDER/0001813311DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback